The FGF-based conjugates retained the receptor binding and cellular trafficking properties of unconjugated FGFs, and demonstrated a selective cytotoxic potential against FGFR1-overproducing lung cancer cell lines [196,197,198,199]. The gene discussed is FGFR1; the disease is lung cancer.